Embrace Scar Therapy Device for Scarring After Wound Closure
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether the Embrace Scar Therapy Device, a silicone dressing, can improve the appearance of scars after surgery. Participants will have a silicone dressing applied to half of their wound, with the other half receiving standard care. Ideal candidates are those scheduled for skin surgery with a wound that can be closed along a flat surface and who can apply dressings and return for follow-up visits.
As an unphased trial, this study allows participants to contribute to innovative research that could enhance post-surgical scar care.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the Embrace Scar Therapy Device is safe for scarring after wound closure?
Research has shown that the Embrace Scar Therapy Device is safe to use. The FDA has approved it, confirming that it meets the safety standards set by the U.S. Food and Drug Administration for its intended purpose. Made with medical-grade silicone, the device is generally safe for all skin types and ages. The silicone contains no extra chemicals or medications, reducing the risk of irritation or allergic reactions. Studies have demonstrated that the device effectively improves the appearance of scars.12345
Why are researchers excited about this trial?
Unlike traditional scar treatments that often involve creams or ointments, the Embrace Scar Therapy Device is a silicone elastomeric dressing that adheres to the skin with a pressure-sensitive adhesive. This innovative approach provides consistent pressure and hydration to the healing wound, which can help minimize scar formation more effectively. Researchers are excited about this treatment because it offers a non-invasive, easy-to-apply alternative that might enhance cosmetic outcomes after wound closure compared to standard care options.
What evidence suggests that the Embrace Scar Therapy Device is effective for improving scar appearance after wound closure?
Research has shown that the Embrace Scar Therapy Device can greatly improve the appearance of scars. In this trial, participants will have one half of their cutaneous wound treated with the Embrace Scar Therapy Device, while the other half will receive standard care. Studies have found that scars treated with this device look much better than those that aren't. In two clinical trials, named IMPROVE and REFINE, the device noticeably reduced the appearance of scars. Both patients and doctors agreed that scars looked better after using the device for 12 months. This silicone dressing works by gently pressing on the skin, helping to prevent scar formation.678910
Who Is on the Research Team?
Daniel B Eisen, MD
Principal Investigator
UC Davis
Are You a Good Fit for This Trial?
This trial is for adults over 18 who can consent, apply dressings themselves, and return for follow-ups. They're scheduled for skin surgery with a wound that's expected to close up right away and is suitable for the Embrace device. It's not for those under 18, incarcerated, allergic to adhesives, pregnant women, mentally handicapped individuals or anyone with collagen vascular disease.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgical Repair and Device Application
Participants undergo surgical repair of cutaneous wounds, followed by application of the embrace device to half of the wound
Treatment
Participants use the embrace device on half of the wound to assess its effectiveness in improving scar cosmesis
Follow-up
Participants are monitored for scar cosmesis and adverse events, with scar assessment conducted using the physician observer scar assessment scale
What Are the Treatments Tested in This Trial?
Interventions
- Embrace Scar Therapy Device
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor